Alison Keyser Metobo, MPH +

Slides:



Advertisements
Similar presentations
HIV Epidemiology Program: Epidemiology of HIV and AIDS in Los Angeles County Presentation to Public Health Commission October 28, 2010 Douglas M. Frye,
Advertisements

Population- based Surveillance of Reportable Diseases in Nursing Home Facilities in Nebraska Manjiri Joshi, MPH + Alison Keyser Metobo, MPH + + Epidemiology.
Measurement: the why and the what
Public Health Preparedness Arizona’s Near Real Time School-based Syndromic Surveillance Program Lea Trujillo PhD, Yue Qiu, MPH, Kenneth Komatsu, MPH, Laura.
REALM project update MRSA and KPC January 26, 2011 Michael Lin, MD MPH on behalf of REALM co-investigators.
EPIDEMIOLOGY AND SURVEILLANCE Southwest Florida Disaster Healthcare Coalition June 13, 2014 Jennifer Roth, MSPH Director of Epidemiology Florida Department.
Unintentional Fall Injuries and Deaths Among MA Older Adults, Ages 65 Years and Over Carrie Huisingh, MPH, Epidemiologist Holly Hackman, MD, MPH, Epidemiologist.
U.S. Surveillance Update Anthony Fiore, MD, MPH CAPT, USPHS Influenza Division National Center for Immunizations and Respiratory Disease Centers for Disease.
Tuberculosis Follow up Care PA Department of Health Role Maxine Kopiec Community Health Nursing Supervisor April 24, 2015.
Prescription Opioid Use and Opioid-Related Overdose Death — TN, 2009–2010 Jane A.G. Baumblatt, MD Centers for Disease Control and Prevention Epidemic Intelligence.
NOSOCOMIAL INFECTIONS Phase 1: Testing the efficacy of Nano-Mg (OH) 2 Dorothea A. Dillman PhD, RN, CCRN, LNC.
CSI 101 Skills Lab 2 Standard Precautions Personal Protective Equipment (PPE) Daryl P. Lofaso, M.Ed, RRT.
Measurement: the why, the what, and the how Paula Griswold, MPH Executive Director Massachusetts Coalition for the Prevention of Medical Errors Nora McElroy,
Indiana Healthcare Associated Infection Initiative Kickoff.
SPM 100 Clinical Skills Lab 1 Standard Precautions Sterile Technique Daryl P. Lofaso, M.Ed, RRT.
Using and Sharing Findings from Surveillance: Rates, Ratios Proportions, Data Display & OUTBREAKS Russ Olmsted, MPH, CIC
A GIS Approach to Staphylococcus Associated Mortality in Texas in 2005 By Samuel F. Barker, MT School of Rural Public Health Texas A&M Health Science Center.
SPM 100 Skills Lab 1 Standard Precautions Sterile Technique Daryl P. Lofaso, M.Ed, RRT Clinical Skills Lab Coordinator.
Vaccines and Related Biological Products Advisory Committee Meeting July 23, 2009 Novel influenza A (H1N1) Epidemiology Update Anthony Fiore, MD, MPH Influenza.
F UNCTIONAL L IMITATIONS IN C ANCER S URVIVORS A MONG E LDERLY M EDICARE B ENEFICIARIES Prachi P. Chavan, MD, MPH Epidemiology PhD Student Xinhua Yu MD.
Urban/Rural Differences in Survival Among Medicare Beneficiaries with Breast Cancer Melony E.S. Sorbero, Ph.D. RAND Corporation Funded by Health Resources.
Evaluation of Brucellosis Surveillance System in the West Bank - Palestine, June 2015 Huda Lahham, PharmD Palestinian Ministry of Health Funded.
Impact of Childhood Hepatitis A Vaccination: New York City Vikki Papadouka, PhD, MPH Jane R. Zucker, MD, MSc Sharon Balter, MD Vasudha Reddy, MPH Kristen.
Correlation of National Influenza Surveillance Data to the Local Experience Kate Goodin, MPH Florida Department of Health Bureau of Epidemiology 6 th Annual.
Using Surveillance Indicators for Vaccine-Preventable Diseases: National Notifiable Diseases Surveillance System Sandra W. Roush, MT, MPH National.
Epidemiological measureas. How do we determine disease frequency for a population?
Trends and Seasonal Patterns in Hospitalization Rates of Clostridium Difficile in the US Elderly Jyotsna S. Jagai, Sara M. Parisi, Meena P. Doshi, Elena.
Sharing Immunization Data between IHS/Tribal Facilities and the Arizona State Immunization Information System Scott Hamstra, MD (IHS) Kimiko Gosney, MS.
Stethoscopes : Clinician’s Gift to Patients Titilayo Oluwabusi MD, Tochi Iroku-Malize MD MPH, Neubert Philippe MD, Oluwafunmilayo Fapohunda MD, Valeria.
The First 400 Patients PROSPECT Meeting June 13, 2016 Jennie Johnstone, MD, PhD, FRCPC St. Joseph’s Health Center Public Health Ontario.
Nosocomial Antibiotic Resistant Organisms
Pengjun Lu, PhD, MPH;1 Kathy Byrd, MD, MPH;2
Epi Gateway: A one-stop surveillance shop
Continuum of Surveillance Updates from Epidemiological Services New Jersey Department of Health Division of HIV, STD and TB Services (DHSTS) Annual.
The Changing Epidemiology of Acute Hepatitis A in Texas
CDC EIS Field Assignments Branch New Jersey Department of Health
NOSOCOMIAL ANTIBIOTIC RESISTANT ORGANISMS
Fig. 3. Target population for vaccines in the 21st century by Rappuoli et al. [25]. (A) The most important vaccines for each age group are reported. (B)
Vibrio Reporting and Surveillance in Louisiana
Mandating hospital and commercial
Trends in Chronic Diseases by Demographic Variables, Hawaii’s Older Population, Hawaii Health Survey (HHS) K. Kromer Baker1, A. T. Onaka1, B. Horiuchi1,
National STD Conference 2008
Dr Asmaa fathy abdellah hassan
Improving SARI Surveillance in Saint Lucia
Nasreen Abdullah, MD, MPH
CSI 101 Skills Lab 3 Universal Precautions and
E. Monee’ Carter-Griffin DNP, RN, ACNP-BC
Summary of WHO PPL, CDC, and ESKAPE pathogen lists
HAI August 30, 2017.
Maria del Rosario, MD, MPH Arianna DeBarr, RN, BSN
Sarah Siddiqui, MD, MPH University of Texas Medical Branch
HAI Sept. 25, 2017.
Report Back Track 6: Population Health Track
Surveillance Lab Meeting
Varicella Surveillance in Texas
Hospital Acquired Infections
A GIS Approach to Staphylococcus Associated Mortality in Texas in 2005
Summary of WHO PPL, CDC, and ESKAPE pathogen lists
Is the prevalence of antibiotic-resistant organisms changing in Canadian hospitals? Comparison of point-prevalence survey results in 2010 and 2012  V.
MRSA=Methicillin resistant Staphylococcus aureus
Surveillance for serious bacterial diseases
M Javanbakht, S Guerry, LV Smith, P Kerndt
Maryland HCW Influenza Vaccination Survey Highlights
Measures of Disease Occurrence
A. Manzur, F. Gudiol  Clinical Microbiology and Infection 
Volume 67, Issue 6, Pages (June 2005)
2017 HIV/AIDS Epidemiology profile Cleveland/cuyahoga county
Varicella Vaccine Efficacy Estimates
National Immunization Conference
Oregon HPV Summit - June 2019 Nasreen Abdullah, MD, MPH
Presentation transcript:

Alison Keyser Metobo, MPH + Population- based Surveillance of Reportable Diseases in Nursing Home Facilities in Nebraska Manjiri Joshi, MPH+ Alison Keyser Metobo, MPH + +Epidemiology Surveillance Response Coordinator

Overview Background Objective Methods Results Next Steps Nursing home increased risk for infection Health outcomes in nursing home residents Baseline for Nebraska cases Objective Methods Estimated incidence rates in nursing home residents Comparing estimated incidence rates in nursing home residents and non-nursing home cases Results Next Steps

Background

Nursing Home residents are at increased risk for infection Advanced Age Group Living Comorbidities Compromised Immunity Need for hospitalization

Health outcomes for nursing home residents Clostridium Difficile infections Influenza Methicillin Resistance Staphylococcus Aureus Vancomycin resistance Enterococci

Compared Nebraska incidence rates with national incidence rates Establish baseline in Nebraska population

2010 - revised reportable disease regulations implemented in Nebraska Conditions added for laboratories reporting via Automated Electronic Laboratory Reporting (ELR) Acinetobacter spp. Streptococcus pneumoniae Enterococcus spp. Influenza Klebsiella spp. Clostridium difficile Staphylococcus aureus Meningococcal disease, invasive (Neisseria meningitidis)

Objectives Calculate estimated incidence rates among nursing home residents for selected agents for 2010 ̶ 2011 Compare estimated incidence rates for nursing home residents and non-nursing home cases who are 65 years and older

METHODS

HL-7 SAS Codes ELR (All Reportable Conditions) Nebraska’s Electronic Diseases Surveillance System (NEDSS) Different line lists with selected variables are created and exported as excel files HL-7 SAS Codes

Nursing home data “Nursing home associated case”- any lab report where patient address = Nursing home address Obtained addresses of all 231 licensed Nursing home facilities Nursing home line list - 2010 and 2011 Selected agents Clostridium Difficile Enterococcus Sp. Influenza Methicillin Resistant Staphylococcus Aureus (MRSA) Non MRSA Staph Streptococcus Pneumonia ** For influenza only positive cases were included

** For influenza only positive cases were included Non-nursing home data Lab report data (ELR) for 2010 ̶ 2011 Selected agents Clostridium Difficile Enterococcus Sp. Influenza Methicillin Resistant Staphylococcus Aureus (MRSA) Non MRSA Staph Streptococcus Pneumonia ** For influenza only positive cases were included

Estimated incidence rates for nursing home residents 2010 ̶ 2011 Total number of licensed beds in Nebraska were used as proxy for convenience as population at risk to calculate the estimated incidence rates in nursing home facilities Incidence Rate = Number of cases Number of licensed beds* * Proxy for population at risk

Compare estimated incidence rates for nursing home residents and non-nursing home cases Assumption : Majority of the population in nursing home was 65 years and above All the licensed beds in Nebraska were used by this population Incidence Rate = Number of cases in nursing home who are 65 yrs and older Total number of licensed beds Non-nursing home cases Number of cases for 65 years and above was included Age specific population for Nebraska was used to calculate the incidence (Denominator) Incidence Rate = Number of cases who are 65 yrs and older Population at risk who are 65 yrs and older

RESULTS

Number and proportion of lab reports for which patient address was available Year Total Count (n) % of available address 2010 2660 2394 90% 2011 7136 6315 88.49%

Total # of Nursing homes in Nebraska Number and proportion for Nursing homes in Nebraska identified in the Lab reports for 2010 and 2011 Total Number of Beds – 16,975 Median: 62 Range: 4 -329 Total # of Nursing homes in Nebraska # identified in 2010, 2011 Percentage % 231 48 20.77

Nursing home associated cases by age and gender -2010 and 2011 Total 2010 2011 Statewide incidence Male Total % Female % Missing gender inform. Age Median Age Range Clostridium Difficile 71 32 39 4.18 59.2 36.6 4.22 79 30-97 Enterococcus Sp. 13 11 2 0.77 38.5 30.8 30.76 67 66-91 Influenza 24 1.41 58.3 41.7 30-99 MRSA 7 4 3 0.41 71.4 28.6 74 66-81 Non MRSA -Staphylococcus Aureus 0.24 25.0 50 78.5 72-81 Streptococcus Pneumonia 10 6 0.59 60.0 40.0 58.5 26-104

Estimated incidence rates for nursing home residents using total number of licensed beds (16,975) in Nebraska

Estimated incidence rates: nursing home residents vs Estimated incidence rates: nursing home residents vs. non nursing cases (65 years and above)

Evaluation Chart Review Validate number of nursing home cases

Next Steps Add question to the investigation: “ If you are a nursing home resident?” Nursing home survey To get number of residents in each nursing home Age and gender information

Limitation Total population in nursing homes Age specific information for nursing home cases Address information No consideration for missing address

Acknowledgement Bryan Buss*, DVM, MPH, DACVPM Eryn Murphyᴪ MS Tom Safranek**, MD * CDC Career Epidemiology Field Officer (CEFO), Nebraska Department of Health and Human Services **State Epidemiologist, Nebraska Department of Health and Human Services ᴪEpidemiology Syndromic surveillance Coordinator

THANK YOU !!! Questions?! manjiri.joshi@nebraska.gov